Renaissance Capital logo

FLGT News

US IPO Weekly Recap: Nutanix skyrockets 131% in year's best IPO debut

NTNX

The third quarter finished with the year's best first-day pop as Nutanix spiked 131% on Friday. September ended as the most active month of 2016 both in terms of IPO pricings (16) and initial filings (18). Nutanix's incredible first-day performance was a fitting end to a quarter marked by the return of tech IPOs and 41% average returns. ...read more

Fulgent Genetics prices IPO at $9, the low end of the downwardly revised range

FLGT

Fulgent Genetics, which offers genetic testing for over 7,500 conditions, raised $38 million by offering 4.2 million shares at $9, the low end of the range of $9 to $11. Fulgent originally planned to raise $60 million by offering 4.6 million shares at $12 to $14, but revised its range on Wednesday. The company plans to list on the Nasdaq under the symbol FLGT. Credit Suisse, Piper...read more

Fulgent Genetics decreases proposed IPO deal size

FLGT

Fulgent Genetics, which offers genetic testing for over 7,500 conditions, lowered the proposed deal size for its upcoming IPO on Wednesday. The Temple City, CA-based company now plans to raise $42 million by offering 4.2 million shares at a price range of $9 to $11. Insiders intend to purchase $11 million worth of shares in the offering. The company had previously filed to...read more

US IPO Week Ahead: Year's largest US tech company to IPO, Nutanix, leads 5-deal week

NTNX

Five IPOs are scheduled to close out the third quarter, putting September on pace to be the year's most active month for IPOs. Nutanix's highly-anticipated IPO will get the most attention, given its growth, scale, and implications for the massive backlog of Silicon Valley tech IPOs with private valuations of more than $1 billion. The other three notable IPOs this...read more